Document Detail


Case series in drug safety: a review to determine characteristics and quality.
MedLine Citation:
PMID:  21077699     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Case series and case reports are a cornerstone of drug safety research; however, the characteristics of case series published in the literature remain poorly examined. A narrative review of case series addressing drug safety, published in the literature between 1 January 2003 and 15 July 2009, and identified through a PubMed search, was conducted in order to determine their characteristics and quality according to the criteria found in the US FDA Pharmacovigilance Guidance 2005. Of 130 publications that met the search criteria, 11.5% included an analytical component and 88.5% were descriptive. The median number of cases included in a given case series was 7 (range 2-2195) and the median time period for recruitment of the cases was 23 months (range 0.5-96). Overall, 43.1% of case series consisted of individual case reports, while 24.6% originated from cohorts and 21% from pharmacovigilance databases. Of the case series, 65.1% concerned adults (age ≥18 years), 11.6% elderly (age ≥65 years) and 8.5% youth (<18 years). Adverse effects involved mainly the skin (18.5%) and the circulatory system (13.8%). The main suspected drug classes (Anatomical Therapeutic Chemical classification) were nervous system drugs (23.1%) and antineoplastic and immunomodulating agents (20.0%). On average, six out of the possible nine US FDA Pharmacovigilance Guidance Criteria were fulfilled, with 27% of publications fulfilling at least seven criteria. Only 10% reported data on co-morbidity. In conclusion, this review highlights the reporting gaps and heterogeneity in published case series with respect to size, recruitment period and quality.
Authors:
Claire Nour Abou Chakra; Antoine Pariente; Marion Pinet; Lenhangmbong Nkeng; Nicholas Moore; Yola Moride
Related Documents :
23317489 - Superficial acral fibromyxoma of the great toe: case report and mini-review of the lite...
9159729 - Adult-onset subacute sclerosing panencephalitis: case reports and review of the literat...
3860599 - Non-union of fractures of the mandible.
8021819 - The impact of lengthening aids reporting delays and uncertainty about underreporting on...
12606829 - Evaluation of national tsutsugamushi disease surveillance--japan, 2000.
9617309 - Epidemiology of human blastomycosis in vilas county, wisconsin. ii: 1991-1996.
22526439 - The cranial dura mater: a review of its history, embryology, and anatomy.
20661149 - The diversity of wound presentation associated with freon contact frostbite injury.
16121089 - Vehicle-assisted suicide resulting in complete decapitation.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Drug safety : an international journal of medical toxicology and drug experience     Volume:  33     ISSN:  0114-5916     ISO Abbreviation:  Drug Saf     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9002928     Medline TA:  Drug Saf     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  1081-8     Citation Subset:  IM    
Affiliation:
Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strat...
Next Document:  Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands.